RxDoctor Payments Data

Shanna Langford

Physician Assistant · Frankfort, KYNPI 1992197222

Payments from drug & device makers

$6,955in general payments, 2019–2025

Across 422 payments — averaging $16.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AbbVie$1K
  • AstraZeneca$881
  • Lilly USA, LLC$751
  • Pfizer$400
  • GSK$356
  • plus $2K from 38 others

What the payments were for

  • Food & beverage$6,939100%
  • Education$160%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,955 in reported general payments places this provider in the 95th percentile of 1,448 physician assistant providers in Kentucky.

See all physician assistant providers in Kentucky

Medicare billing

Part B allowed, 2024
$32,356
Medicare patients
157
Services billed
643

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin70$69,781
EliquisApixaban36$48,161
Trelegy ElliptaFluticasone/Umeclidin/Vilanter60$44,168
OzempicSemaglutide19$34,328
MounjaroTirzepatide26$32,444
JanuviaSitagliptin Phosphate34$29,034
TrulicityDulaglutide14$14,947
VascepaIcosapent Ethyl19$6,763
Bevespi AerosphereGlycopyrrolate/Formoterol Fum11$4,517
Lantus SolostarInsulin Glargine,hum.Rec.Anlog28$3,779
Aripiprazole18$3,731
Albuterol Sulfate HfaAlbuterol Sulfate146$3,388
Levothyroxine Sodium161$2,389
Memantine Hcl ErMemantine Hcl13$2,083
Omeprazole209$1,937

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$248$69,78170 claims
PfizerEliquis$400$48,16136 claims
Lilly USA, LLCMounjaro, Trulicity$751$47,39140 claims
GSKTrelegy Ellipta$356$44,16860 claims
Novo NordiskOzempic$1,139$34,32819 claims
MerckJanuvia$12$29,03434 claims
AstraZenecaBevespi Aerosphere$881$4,51711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,448 physician assistant providers in Kentucky.

Other physician assistant in Frankfort

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →